Literature DB >> 11841990

Physiology of iron transport and the hemochromatosis gene.

Antonello Pietrangelo1.   

Abstract

Iron is essential for fundamental cell functions but is also a catalyst for chemical reactions involving free radical formation, potentially leading to oxidative stress and cell damage. Cellular iron levels are therefore carefully regulated to maintain an adequate substrate while also minimizing the pool of potentially toxic "free iron." The main control of body iron homeostasis in higher organisms is placed in the duodenum, where dietary iron is absorbed, whereas no controlled means of eliminating unwanted iron have evolved in mammals. Hereditary hemochromatosis, the prototype of deregulated iron homeostasis in humans, is due to inappropriately increased iron absorption and is commonly associated to a mutated HFE gene. The HFE protein is homologous to major histocompatibility complex class I proteins but is not an iron carrier, whereas biochemical and cell biological studies have shown that the transferrin receptor, the main protein devoted to cellular uptake of transferrin iron, interacts with HFE. This review focuses on recent advances in iron research and presents a model of HFE function in iron metabolism.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11841990     DOI: 10.1152/ajpgi.00404.2001

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  19 in total

Review 1.  Nutritional genomics.

Authors:  Ruan Elliott; Teng Jin Ong
Journal:  BMJ       Date:  2002-06-15

2.  Serum ferritin predicts prognosis in hemodialysis patients: the Nishinomiya study.

Authors:  Yukiko Hasuike; Hiroshi Nonoguchi; Masanori Tokuyama; Mai Ohue; Takanori Nagai; Mana Yahiro; Masayoshi Nanami; Yoshinaga Otaki; Takeshi Nakanishi
Journal:  Clin Exp Nephrol       Date:  2010-05-14       Impact factor: 2.801

3.  Heart failure and malignant ventricular tachyarrhythmias due to hereditary hemochromatosis with iron overload cardiomyopathy.

Authors:  A W Demant; A Schmiedel; R Büttner; T Lewalter; C Reichel
Journal:  Clin Res Cardiol       Date:  2007-08-20       Impact factor: 5.460

4.  Iron status in mice carrying a targeted disruption of lactoferrin.

Authors:  Pauline P Ward; Marisela Mendoza-Meneses; Grainne A Cunningham; Orla M Conneely
Journal:  Mol Cell Biol       Date:  2003-01       Impact factor: 4.272

5.  Pro-hepcidin: expression and cell specific localisation in the liver and its regulation in hereditary haemochromatosis, chronic renal insufficiency, and renal anaemia.

Authors:  H Kulaksiz; S G Gehrke; A Janetzko; D Rost; T Bruckner; B Kallinowski; W Stremmel
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

Review 6.  The SLC40 basolateral iron transporter family (IREG1/ferroportin/MTP1).

Authors:  Andrew T McKie; David J Barlow
Journal:  Pflugers Arch       Date:  2003-06-27       Impact factor: 3.657

Review 7.  Manipulation of iron to determine survival: competition between host and pathogen.

Authors:  Nihay Laham; Rachel Ehrlich
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

8.  Increased DMT1 but not IREG1 or HFE mRNA following iron depletion therapy in hereditary haemochromatosis.

Authors:  T Kelleher; E Ryan; S Barrett; M Sweeney; V Byrnes; C O'Keane; J Crowe
Journal:  Gut       Date:  2004-08       Impact factor: 23.059

9.  Ferroportin and erythroid cells: an update.

Authors:  Luciano Cianetti; Marco Gabbianelli; Nadia Maria Sposi
Journal:  Adv Hematol       Date:  2010-08-11

10.  A precious metal: Iron, an essential nutrient for all cells.

Authors:  G Cairo; F Bernuzzi; S Recalcati
Journal:  Genes Nutr       Date:  2006-03       Impact factor: 5.523

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.